CGRP Forum is made possible thanks to support from AbbVie, Lilly, Organon and Pfizer, all of whom have no influence or control of editorial content. More information is available here »

CGRP Education & Research Forum
Already a member? Become a member Register
youtubeLinkedIn
Latest:

Professor Hans-Christoph Diener MD, PhD, FAHA, FAAN

Editorial Board
Senior Professor for Clinical Neurosciences

Department of Neurology
University Duisburg-Essen
Hufelandstrasse 55
45122 Essen
Germany

Hans-Christoph Diener is Senior Professor of Clinical Neurosciences at the Department of Neurology and Director of the Essen Headache Centre at the University of Duisburg-Essen in Germany. He was Chairman of the Department of Neurology in Essen from 1989 to 2016. He was President of the German Neurological Society, President of the European Headache Federation (EHF), and the International Headache Society (IHS) and chairs the German Headache Consortium and the German Stroke Data Bank.

Professor Diener has authored or co-authored 881 articles in peer-reviewed journals (180 as first author, 19 in the NEJM), 311 invited reviews, and 332 book chapters, and served as the editor or author of 84 books. His h index is 100. He is the editor of Aktuelle Neurologie, Stroke News, Kopfschmerz (Headache ) News and Arzneimitteltherapie, deputy editor of Cephalalgia and serves on the editorial boards of Lancet Neurology, Cerebrovascular Diseases, Future Neurology, The International Journal of Clinical Practice, European Neurology and Reviews in Contemporary Pharmacotherapy.

Professor Diener has been the PI of more than 30 trials on the acute treatment and prophylaxis of headache disorders.

« Back to Editorial Board

Disclosures

Professor Diener received honoraria for participation in clinical trials, contribution to advisory boards or oral presentations from: Addex Pharma, Alder, Allergan, Almirall, Amgen, Autonomic Technology, AstraZeneca, Bayer Vital, Berlin Chemie, Böhringer Ingelheim, Bristol-Myers Squibb, Chordate, Coherex, CoLucid, Electrocore, GlaxoSmithKline, Grünenthal, Janssen-Cilag, Labrys Bioloogicals, Lilly, La Roche, 3M Medica, Medtronic, Menarini, Minster, MSD, Neuroscore, Novartis, Johnson & Johnson, Pierre Fabre, Pfizer, Schaper and Brümmer, Sanofi, St. Jude, Teva and Weber & Weber.  Financial support for research projects was provided by Allergan, Almirall, AstraZeneca, Bayer, Electrocore, GSK, Janssen-Cilag, MSD and Pfizer. Headache research at the Department of Neurology in Essen is supported by the German Research Council (DFG), the German Ministry of Education and Research (BMBF) and the European Union.

Professor Diener has no ownership interest and does not own stocks of any pharmaceutical company.  He serves on the editorial boards of Cephalalgia and Lancet Neurology. He also chairs the Clinical Guidelines Committee of the German Society of Neurology.

Articles by Hans-Christoph Diener


Educational Partners and Supporters
AbbVie logo

This program is funded in part via an independent educational grant from AbbVie.

Lilly logo

Organon logo

Organon has provided sponsorship towards this independent resource. Organon has had no editorial input or control over content, nor opportunity to influence.

Pfizer logo

Financial support was provided as GMG Knowledge Gap Grant from Pfizer Inc, Pfizer have provided only financial support and had no input into the content provided.

Editorial PolicyCGRP Forum is an expert resource for clinicians and healthcare professionals working with migraine patients. All patients should discuss their medication with their healthcare professional. Unless otherwise indicated, opinions expressed in the CGRP Education and Research Forum are those of the contributors. Although every effort is made to ensure accuracy and avoid mistakes, no liability on the part of the CGRP Forum, the editors or the editorial board is accepted for the consequences of any misleading or inaccurate information.
Partnership & OutreachThrough its unique global network of researchers and clinicians, the CGRP Education and Research Forum connects academic institutions, research organisations and societies which share the Forum’s commitment to the reduction of the burden, disability and cost associated with migraine.




© 2024 | Privacy Policy | Editorial Policy | Governance | Disclaimer Statement | Partnership & Outreach | Educational Partners and Supporters |
MENU